174 related articles for article (PubMed ID: 24533532)
1. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
Yuan G; Wu L; Huang M; Li N; An J
Radiat Oncol; 2014 Feb; 9():55. PubMed ID: 24533532
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
3. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
Yokoyama Y; Takano T; Nakahara K; Shoji T; Sato H; Yamada H; Yaegashi N; Okamura K; Kurachi H; Sugiyama T; Tanaka T; Sato A; Tase T; Mizunuma H
Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
Jakubowicz J; Blecharz P; Skotnicki P; Reinfuss M; Walasek T; Luczynska E
Eur J Gynaecol Oncol; 2014; 35(4):393-9. PubMed ID: 25118480
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
[TBL] [Abstract][Full Text] [Related]
8. A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
Okonogi N; Wakatsuki M; Kato S; Karasawa K; Miyasaka Y; Murata H; Nakano T; Kamada T; Shozu M;
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):631-639. PubMed ID: 30825494
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
[TBL] [Abstract][Full Text] [Related]
10. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
[TBL] [Abstract][Full Text] [Related]
11. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
13. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Weekly versus Three Weekly Cisplatin with Radiotherapy in Locally Advanced Uterine Cervical Carcinoma.
Hasan MR; Bari MA; Alam S; Sah GS
JNMA J Nepal Med Assoc; 2018; 56(213):842-847. PubMed ID: 31065118
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: a phase II study.
Varghese SS; Ram TS; Pavamani SP; Thomas EM; Jeyaseelan V; Viswanathan PN
J Cancer Res Ther; 2014; 10(2):330-6. PubMed ID: 25022387
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract][Full Text] [Related]
19. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
Niibe Y; Onda T; Matsuo K; Inoue Y; Hayakawa K
Anticancer Res; 2017 Dec; 37(12):6983-6988. PubMed ID: 29187484
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]